Raloxifene

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Raloxifene trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT06944145

New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia

SRD5A2 is a critical enzyme for prostatic development and growth, and the SRD5A2 inhibitor, finasteride, is used to treat benign prostatic hyperplasia (BPH). SR…

United States242 participantsStarted 2025-12-03

Treatment: raloxifene, Finasteride

All recent trials (65 shown)

Active — Not RecruitingPhase 2/3

NCT06062810

Bioequivalence ANDA SNP Clinical Study - Raloxifene and Single Nucleotide Polymorphisms

Explore the relationship between drug target ER gene single nucleotide polymorphisms and Raloxifene therapeutic effects in patients with Breast Cancer LCIS, bas…

United States600 participantsStarted 2025-06-21

Treatment: Raloxifene - Usual, Raloxifene - Study

Not Yet RecruitingPhase 2

NCT07470606

Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain

The study investigators are testing to see if patients receiving radiation treatment for brain cancer along with raloxifene plus memantidine take longer to deve…

United States108 participantsStarted 2026-03

Treatment: Memantine, Raloxifene

Raloxifene

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia

All recent trials (65 shown)

Bioequivalence ANDA SNP Clinical Study - Raloxifene and Single Nucleotide Polymorphisms

Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia

All recent trials (65 shown)

Bioequivalence ANDA SNP Clinical Study - Raloxifene and Single Nucleotide Polymorphisms

Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain

Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome

Comparison of Tibolone and Raloxifene on Bone Mineral Density in Osteopenic Postmenopausal Women (P06090)

A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)

Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)

Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women

Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women…

Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.

Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?

Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast…

Comparative Antiresorptive Efficacy Discontinuation of Denosumab

Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis

Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder

An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol

Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake

Raloxifene on Coagulation System in the Postmenopausal Women

Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia

Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

Osteoporosis Treatment in Post-menopausal Women